| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.0099 | 0.9 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |